Professional Documents
Culture Documents
Darif Brand PPT - Q4 PDF
Darif Brand PPT - Q4 PDF
35 31
29 28 28
30 26 25 25
25 20 21
20 16
15
10
5
0
YTD Target
Brands
PCPM PCPM
Darif 26k 30k
Regusol - Brand performance
0.1
0.09
0.05
0
April`16 May`16 June`16
Mumbai Pune Indore
Values in Lacs
Below par performers
MR Name HQ YTD Dec 15 PCPM YTD Dec 16 PCPM PGR
Gain /
Company
Brands Val Lacs % MS Loss of % GR
Name
MS
DARIFENACIN 1,989 3.85 -0.09 18.43
DARITEN OD Ranbaxy 713 35.85 4.85 36.97
DARIF Alembic 469 23.55 -1.50 11.33
DARILONG Sun 420 21.13 -3.25 2.63
VESIGARD Cipla 224 11.28 -0.32 15.20
DERITAS Intas 163 8.18 0.21 21.69
IMS May`16
Market Competition
Gain /
Company
Brands Val Lacs % MS Loss of % GR
Name
MS
SOLIFENACIN 3,448 6.67 1.09 44.96
SOLITEN Ranbaxy 1,735 50.32 -6.58 28.19
BISPEC DRL 780 22.61 -0.70 40.66
SOLICEPT Lupin 516 14.96 -1.78 29.58
SOLIACT Cipla 202 5.87 5.87 999.00
REGUSOL Alembic 93 2.69 2.69 999.00
VESIACT FTS 74 2.14 -0.92 1.55
FLOSLO Intas 48 1.41 1.41 999.00
IMS May`16
WCW - Report Last year This year
18
Page:18
GIMMICK LBL 1
Front
Qty-20/BM
GIMMICK LBL 1
Inside spread with pop-up
GIMMICK LBL 1
Back
GIMMICK LBL 2
Front
Qty-20/BM
GIMMICK LBL 2
After Opening
GIMMICK LBL 2
Full open spread
GIMMICK LBL 2
Back
DARIF CHIT PAD
• CP /Urologists/Nephrologists
• Dr., Presenting to you Darif to treat OAB and UUI episodes
experienced by your Patients.
• Qty - 30 /BM
VA Communication
OAB Portfolio Opener Page
DARIF VA PAGE ON OAB & UUI – Focusing
on Warning Time
Lacs/Month
Thank You